Stock ASTH ASTRANA HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Astrana Health, Inc.

Equities

ASTH

US03763A2078

Real-time Estimate Cboe BZX
Other stock markets
 11:31:15 2024-06-07 am EDT 		5-day change 1st Jan Change
40.98 USD -0.98% Intraday chart for Astrana Health, Inc. -0.94% +7.15%
May. 30 Baird Starts Astrana Health With Outperform Rating, $54 Price Target MT
May. 16 Transcript : Astrana Health, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM

Evolution of the average Target Price on Astrana Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2a3f0f5ef4212.zNlthyy_G7MhwzEt-6zxIfR5cyVNAyM0Jt0yTyCNOX0.uewO8nrwTfJIl1B9yeGkbo5MJ3MnbEd8aZNjBWbAaBT0lRfdfPNe4lf1cA~28ae167fa44568e4e071a3b84550b182

Analyst Recommendations on Astrana Health, Inc.

Baird Starts Astrana Health With Outperform Rating, $54 Price Target MT
Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating MT
Jefferies Starts Coverage on Apollo Medical With Buy Rating MT
Stifel Starts Coverage on Apollo Medical with Buy Rating, $45 Price Target MT
Truist Initiates Apollo Medical With Hold Rating, Price Target is $41 MT
BTIG Initiates Apollo Medical at Buy Rating With $45 Price Target MT
BofA Securities Initiates Apollo Medical at Neutral With $44 Price Target MT
Lake Street Adjusts Price Target on Apollo Medical Holdings to $60 From $40, Maintains Buy Rating MT
Lake Street Initiates Apollo Medical With Buy Rating, Sets $40 Price Target MT
William Blair Initiates Coverage on Apollo Medical Holdings With Outperform Rating MT
Barclays Adjusts Price Target on Apollo Medical Holdings to $57 From $50, Reiterates Equalweight Rating MT
Colliers Securities Assumes Apollo Medical Holdings at Buy with $93 Price Target MT
APOLLO MEDICAL : Barclays Starts Apollo Medical Holdings at Equal-Weight With $92 Price Target MT
APOLLO MEDICAL : Colliers Adjusts Price Target on Apollo Medical Holdings to $75 From $36, Maintains Buy Rating MT
Apollo Medical Holdings, Inc. Announces Successful Completion of Debt Refinancing, Reducing Annual Interest Rate Spread by 50 Basis Points CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
41.39 USD
Average target price
52.71 USD
Spread / Average Target
+27.36%
High Price Target
70 USD
Spread / Highest target
+69.12%
Low Price Target
44 USD
Spread / Lowest Target
+6.31%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Astrana Health, Inc.

Baird
Stifel Nicolaus
Truist Securities
Jefferies & Co.
BTIG
BofA Securities
Lake Street
William Blair & Co.
Barclays
Colliers Securities

Ratings for Astrana Health, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ASTH Stock
  4. Consensus Astrana Health, Inc.